HIP
CRL icon

HUB Investment Partners’s Charles River Laboratories CRL Stock Holding History

HUB Investment Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Sell
1,310
-142
-10% -$25.3K 0.01% 999
2026
Q1 		$250K Sell
1,452
-113
-7% -$21K 0.01% 900
2025
Q4 		$312K Buy
+1,565
New +$284K 0.01% 657

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

HUB Investment Partners's CRL Position: Q2 2026 in Review

HUB Investment Partners reduced its Charles River Laboratories (CRL) stake by 9.8% in Q2 2026, selling an estimated $25.3K and leaving 1,310 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #999.

HUB Investment Partners first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. The position peaked at $312K in Q4 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • HUB Investment Partners held 1,310 shares of Charles River Laboratories worth $297K as of Q2 2026.
  • HUB Investment Partners sold 142 Charles River Laboratories shares in Q2 2026, an estimated $25.3K.
  • Charles River Laboratories made up 0.01% of HUB Investment Partners's portfolio in Q2 2026, its #999 holding.
  • HUB Investment Partners first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • HUB Investment Partners's Charles River Laboratories position peaked at $312K in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.